SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+12.64%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$703M
AUM Growth
+$703M
(+24%)
Cap. Flow
+$36.3M
Cap. Flow
% of AUM
5.16%
Top 10 Holdings %
Top 10 Hldgs %
37.2%
Holding
186
New
62
Increased
29
Reduced
37
Closed
42
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$25.3M |
| 2 |
AbbVie
ABBV
|
$23.8M |
| 3 |
Merck
MRK
|
$21.6M |
| 4 |
ENDP
Endo International plc
ENDP
|
$18.8M |
| 5 |
Amgen
AMGN
|
$17.8M |
Top Sells
| 1 |
Ormat Technologies
ORA
|
$34.5M |
| 2 |
Novartis
NVS
|
$33.5M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$18.2M |
| 4 |
Biogen
BIIB
|
$12.7M |
| 5 |
ISRL
Isramco Inc
ISRL
|
$11.1M |
Sector Composition
| 1 | Healthcare | 73.44% |
| 2 | Technology | 3.56% |
| 3 | Industrials | 2.47% |
| 4 | Consumer Discretionary | 2.06% |
| 5 | Utilities | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Celldex Therapeutics
CLDX
$1.57B
| $2.93M | 0.3% |
+105,000
| New | +$2.93M |
|
|
RCPT
77
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $2.89M | 0.3% |
17,500
-12,500
| -42% | -$2.06M |
|
|
AERI
78
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.82M | 0.29% |
90,000
+1,484
| +2% | +$46.5K |
|
|
EPZM
79
DELISTED
Epizyme, Inc
EPZM
| $2.82M | 0.29% |
+150,000
| New | +$2.82M |
|
|
MDCO
80
DELISTED
Medicines Co
MDCO
| $2.8M | 0.29% |
100,000
| – | – |
|
|
TTPH
81
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.75M | 0.29% |
+75,000
| New | +$2.75M |
|
|
IMDZ
82
DELISTED
Immune Design Corp.
IMDZ
| $2.73M | 0.28% |
+129,440
| New | +$2.73M |
|
83
Travere Therapeutics
TVTX
$1.75B
| $2.67M | 0.28% |
+111,392
| New | +$2.67M |
|
84
Atara Biotherapeutics
ATRA
$88.7M
| $2.64M | 0.28% |
+63,579
| New | +$2.64M |
|
|
PAY
85
DELISTED
Verifone Systems Inc
PAY
| $2.64M | 0.27% |
+75,545
| New | +$2.64M |
|
|
TRVN
86
DELISTED
Trevena, Inc.
TRVN
| $2.56M | 0.27% |
391,811
-158,000
| -29% | -$1.03M |
|
87
uniQure
QURE
$954M
| $2.49M | 0.26% |
102,415
-66,000
| -39% | -$1.61M |
|
|
OTIC
88
DELISTED
Otonomy, Inc.
OTIC
| $2.48M | 0.26% |
+70,000
| New | +$2.48M |
|
89
Adverum Biotechnologies
ADVM
$68.2M
| $2.43M | 0.25% |
+60,000
| New | +$2.43M |
|
90
Snap-on
SNA
$16.8B
| $2.26M | 0.23% |
15,340
-5,800
| -27% | -$853K |
|
91
TherapeuticsMD
TXMD
$12.7M
| $2.21M | 0.23% |
+365,000
| New | +$2.21M |
|
92
Sangamo Therapeutics
SGMO
$161M
| $2.2M | 0.23% |
140,000
-60,000
| -30% | -$941K |
|
93
Summit Therapeutics
SMMT
$17.5B
| $2.17M | 0.23% |
+175,000
| New | +$2.17M |
|
94
Rocket Pharmaceuticals
RCKT
$358M
| $2.17M | 0.23% |
+400,000
| New | +$2.17M |
|
95
iShares US Home Construction ETF
ITB
$3.18B
| $2.15M | 0.22% |
+76,000
| New | +$2.15M |
|
96
Booking.com
BKNG
$181B
| $2.12M | 0.22% |
+1,820
| New | +$2.12M |
|
97
Wabtec
WAB
$32.7B
| $2.04M | 0.21% |
+21,500
| New | +$2.04M |
|
|
SRCL
98
DELISTED
Stericycle Inc
SRCL
| $2.04M | 0.21% |
+14,500
| New | +$2.04M |
|
|
TRIL
99
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.92M | 0.2% |
+95,000
| New | +$1.92M |
|
|
MRNS
100
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.92M | 0.2% |
213,533
-80,000
| -27% | -$719K |
|